Theravance Biopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MADISON AVENUE PARTNERS, LP | 02/17/2026 | 9.51 M | $177.95 M | 0.00% | 18.83% |
| WEISS ASSET MANAGEMENT LP | 02/17/2026 | 7.46 M | $139.52 M | 0.00% | 14.76% |
| NEWTYN MANAGEMENT, LLC | 02/17/2026 | 4.30 M | $80.45 M | -13.13% | 8.51% |
| BLACKROCK, INC. | 02/12/2026 | 4.05 M | $75.79 M | -0.45% | 8.02% |
| IRENIC CAPITAL MANAGEMENT LP | 02/17/2026 | 2.76 M | $51.66 M | 0.00% | 5.47% |
| VANGUARD GROUP INC | 01/29/2026 | 2.37 M | $44.29 M | 7.04% | 4.69% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.26 M | $23.57 M | 4.19% | 2.49% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 1.17 M | $21.81 M | 7.03% | 2.31% |
| STATE STREET CORP | 02/13/2026 | 1.10 M | $20.62 M | 4.36% | 2.18% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 963.26 K | $18.02 M | 32.54% | 1.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 938.72 K | $17.57 M | 4.54% | 1.86% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 858.96 K | $16.07 M | 12.03% | 1.70% |
| MORGAN STANLEY | 02/13/2026 | 803.12 K | $15.03 M | 33.95% | 1.59% |
| OASIS MANAGEMENT CO LTD. | 02/13/2026 | 727.16 K | $13.61 M | -35.01% | 1.44% |
| UBS GROUP AG | 01/29/2026 | 570.43 K | $10.67 M | 10.94% | 1.13% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 537.34 K | $10.05 M | 132.34% | 1.06% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 473.50 K | $8.86 M | 124.36% | 0.94% |
| MARSHALL WACE, LLP | 02/13/2026 | 418.63 K | $7.83 M | 17.05% | 0.83% |
| JPMORGAN CHASE & CO | 02/11/2026 | 416.41 K | $7.79 M | 95.40% | 0.82% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 404.14 K | $7.56 M | -2.55% | 0.80% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 400.50 K | $7.49 M | 214.84% | 0.79% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 379.50 K | $7.10 M | 89.47% | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 351.25 K | $6.57 M | 32.90% | 0.70% |
| PACER ADVISORS, INC. | 02/24/2026 | 338.96 K | $6.34 M | 100.00% | 0.67% |
| NORTHERN TRUST CORP | 02/17/2026 | 329.93 K | $6.17 M | -3.33% | 0.65% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 324.32 K | $6.07 M | -13.19% | 0.64% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 313.29 K | $5.86 M | -2.14% | 0.62% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 02/10/2026 | 308.60 K | $5.77 M | -0.68% | 0.61% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 290.86 K | $5.44 M | 12.46% | 0.58% |
| CITADEL ADVISORS LLC | 02/17/2026 | 235.70 K | $4.41 M | 363.37% | 0.47% |
| HRT FINANCIAL LP | 02/12/2026 | 232.85 K | $4.36 M | 892.76% | 0.46% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 221.66 K | $4.15 M | 26.78% | 0.44% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 208.78 K | $3.91 M | 100.00% | 0.41% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 208.77 K | $3.91 M | 100.00% | 0.41% |
| TUDOR INVESTMENT CORP ET AL | 02/17/2026 | 190.13 K | $3.56 M | 272.45% | 0.38% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 182.49 K | $3.41 M | 26.26% | 0.36% |
| PARK WEST ASSET MANAGEMENT LLC | 02/17/2026 | 181.51 K | $3.40 M | -85.86% | 0.36% |
| INVESCO LTD. | 02/19/2026 | 177.95 K | $3.33 M | 622.18% | 0.35% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 174.54 K | $2.50 M | -3.83% | 0.35% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 174.41 K | $3.26 M | 604.61% | 0.35% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 136.98 K | $2.56 M | 459.28% | 0.27% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 122.97 K | $2.30 M | -5.52% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 118.55 K | $2.22 M | 3.47% | 0.23% |
| MAN GROUP PLC | 02/17/2026 | 117.08 K | $2.19 M | 46.74% | 0.23% |
| BARCLAYS PLC | 02/13/2026 | 111.62 K | $2.09 M | -3.27% | 0.22% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 106.18 K | $1.99 M | -79.86% | 0.21% |
| INTEGRATED QUANTITATIVE INVESTMENTS LLC | 02/12/2026 | 105.14 K | $1.97 M | 317.70% | 0.21% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 104.29 K | $1.95 M | 8.94% | 0.21% |
| PDT PARTNERS, LLC | 02/17/2026 | 92.56 K | $1.73 M | -15.63% | 0.18% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 90.73 K | $1.70 M | -1.83% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Theravance Biopharma Inc institutional Ownership - FAQ's
During the previous two years, 243 institutional investors and hedge funds held shares of Theravance Biopharma Inc. The most heavily invested institutionals were:
UBS Group AG: 764,105
Assenagon Asset Management S.A.: 404,147
Nuveen, LLC: 127,678
Jackson Creek Investment Advisors LLC: 118,560
Bank of New York Mellon Corp: 114,067
CWA Asset Management Group, LLC: 94,902
98.16% of Theravance Biopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 78.06 M shares in the last 24 months. This purchase volume represents approximately $1.09 B in transactions.